# Raymond James Financial Inc: financial statements, quarterly

RJF · NYSE · CIK 720005 · [Financials](/sectors/financials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/rjf.md) · [Financials](/companies/rjf/financials.md) · [Filings](/companies/rjf/filings.md) · [Insiders](/companies/rjf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rjf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,515 d](/filings/0000720005-25-000093.md) | [3,520](/filings/0000720005-25-000025.md) | [3,638](/filings/0000720005-25-000053.md) | [3,762](/filings/0000720005-25-000072.md) | [4,003 d](/filings/0000720005-25-000093.md) | [4,035](/filings/0000720005-26-000035.md) | [3,845](/filings/0000720005-26-000051.md) | [3,842](/filings/0000720005-26-000070.md) | [4,190 d](/filings/0000720005-25-000093.md) | [4,176](/filings/0000720005-26-000035.md) | [4,262](/filings/0000720005-26-000051.md) | [4,362](/filings/0000720005-26-000070.md) |
| Interest expense | $m | [462 d](/filings/0000720005-23-000079.md) | [507](/filings/0000720005-24-000019.md) | [520](/filings/0000720005-24-000034.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [151 d](/filings/0000720005-25-000093.md) | [132](/filings/0000720005-25-000025.md) | [133](/filings/0000720005-25-000053.md) | [152](/filings/0000720005-25-000072.md) | [158 d](/filings/0000720005-25-000093.md) | [149](/filings/0000720005-26-000035.md) | [176](/filings/0000720005-26-000051.md) | [127](/filings/0000720005-26-000070.md) | [127 d](/filings/0000720005-25-000093.md) | [165](/filings/0000720005-26-000035.md) | [191](/filings/0000720005-26-000051.md) | [155](/filings/0000720005-26-000070.md) |
| Net income | $m | [434 d](/filings/0000720005-25-000093.md) | [498](/filings/0000720005-25-000025.md) | [476](/filings/0000720005-25-000053.md) | [492](/filings/0000720005-25-000072.md) | [602 d](/filings/0000720005-25-000093.md) | [600](/filings/0000720005-26-000035.md) | [495](/filings/0000720005-26-000051.md) | [436](/filings/0000720005-26-000070.md) | [604 d](/filings/0000720005-25-000093.md) | [563](/filings/0000720005-26-000035.md) | [544](/filings/0000720005-26-000051.md) | [595](/filings/0000720005-26-000070.md) |
| Diluted EPS | $ per share | not reported | [2.32](/filings/0000720005-25-000025.md) | [2.22](/filings/0000720005-25-000053.md) | [2.31](/filings/0000720005-25-000072.md) | not reported | [2.86](/filings/0000720005-26-000035.md) | [2.36](/filings/0000720005-26-000051.md) | [2.12](/filings/0000720005-26-000070.md) | not reported | [2.79](/filings/0000720005-26-000035.md) | [2.72](/filings/0000720005-26-000051.md) | [3.01](/filings/0000720005-26-000070.md) |
| Basic EPS | $ per share | not reported | [2.38](/filings/0000720005-25-000025.md) | [2.27](/filings/0000720005-25-000053.md) | [2.37](/filings/0000720005-25-000072.md) | not reported | [2.94](/filings/0000720005-26-000035.md) | [2.41](/filings/0000720005-26-000051.md) | [2.16](/filings/0000720005-26-000070.md) | not reported | [2.85](/filings/0000720005-26-000035.md) | [2.76](/filings/0000720005-26-000051.md) | [3.06](/filings/0000720005-26-000070.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [9.3](/filings/0000720005-25-000093.md) | [10.2](/filings/0000720005-25-000025.md) | [10.0](/filings/0000720005-25-000053.md) | [9.1](/filings/0000720005-25-000072.md) | [11.0](/filings/0000720005-25-000093.md) | [10.0](/filings/0000720005-26-000035.md) | [9.7](/filings/0000720005-26-000051.md) | [9.2](/filings/0000720005-26-000070.md) | [11.4](/filings/0000720005-26-000070.md) | [9.9](/filings/0000720005-26-000035.md) | [11.2](/filings/0000720005-26-000051.md) | [10.0](/filings/0000720005-26-000070.md) |
| Total assets | $bn | [78.4](/filings/0000720005-24-000069.md) | [80.1](/filings/0000720005-24-000019.md) | [81.2](/filings/0000720005-24-000034.md) | [80.6](/filings/0000720005-24-000051.md) | [83.0](/filings/0000720005-25-000093.md) | [82.3](/filings/0000720005-25-000025.md) | [83.1](/filings/0000720005-25-000053.md) | [84.8](/filings/0000720005-25-000072.md) | [88.2](/filings/0000720005-26-000070.md) | [88.8](/filings/0000720005-26-000035.md) | [91.9](/filings/0000720005-26-000051.md) | [94.2](/filings/0000720005-26-000070.md) |
| Total liabilities | $bn | [68.2](/filings/0000720005-24-000069.md) | [69.3](/filings/0000720005-24-000019.md) | [70.3](/filings/0000720005-24-000034.md) | [69.4](/filings/0000720005-24-000051.md) | [71.3](/filings/0000720005-25-000093.md) | [70.4](/filings/0000720005-25-000025.md) | [70.9](/filings/0000720005-25-000053.md) | [72.6](/filings/0000720005-25-000072.md) | [75.7](/filings/0000720005-26-000070.md) | [76.2](/filings/0000720005-26-000035.md) | [79.3](/filings/0000720005-26-000051.md) | [81.5](/filings/0000720005-26-000070.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [10.2](/filings/0000720005-24-000069.md) | [10.8](/filings/0000720005-24-000019.md) | [11.0](/filings/0000720005-24-000034.md) | [11.2](/filings/0000720005-24-000051.md) | [11.7](/filings/0000720005-25-000093.md) | [11.9](/filings/0000720005-25-000025.md) | [12.2](/filings/0000720005-25-000053.md) | [12.3](/filings/0000720005-25-000072.md) | [12.5](/filings/0000720005-26-000070.md) | [12.6](/filings/0000720005-26-000035.md) | [12.6](/filings/0000720005-26-000051.md) | [12.7](/filings/0000720005-26-000070.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [434 d](/filings/0000720005-25-000093.md) | [543](/filings/0000720005-25-000025.md) | [391 d](/filings/0000720005-25-000053.md) | [711 d](/filings/0000720005-25-000072.md) | [510 d](/filings/0000720005-25-000093.md) | [830](/filings/0000720005-26-000035.md) | [117 d](/filings/0000720005-26-000051.md) | [691 d](/filings/0000720005-26-000070.md) | [796 d](/filings/0000720005-25-000093.md) | [(10.0)](/filings/0000720005-26-000035.md) | [1,099 d](/filings/0000720005-26-000051.md) | [(246) d](/filings/0000720005-26-000070.md) |
| Capital expenditure | $m | [51.0 d](/filings/0000720005-25-000093.md) | [50.0](/filings/0000720005-25-000025.md) | [49.0 d](/filings/0000720005-25-000053.md) | [56.0 d](/filings/0000720005-25-000072.md) | [50.0 d](/filings/0000720005-25-000093.md) | [41.0](/filings/0000720005-26-000035.md) | [46.0 d](/filings/0000720005-26-000051.md) | [57.0 d](/filings/0000720005-26-000070.md) | [44.0 d](/filings/0000720005-25-000093.md) | [46.0](/filings/0000720005-26-000035.md) | [45.0 d](/filings/0000720005-26-000051.md) | [62.0 d](/filings/0000720005-26-000070.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [220](/filings/0000720005-24-000019.md) | [219](/filings/0000720005-24-000034.md) | [215](/filings/0000720005-24-000051.md) | [214](/filings/0000720005-25-000025.md) | [213](/filings/0000720005-25-000053.md) | [212](/filings/0000720005-25-000072.md) | [209](/filings/0000720005-26-000035.md) | [209](/filings/0000720005-26-000051.md) | [206](/filings/0000720005-26-000070.md) | [201](/filings/0000720005-26-000035.md) | [199](/filings/0000720005-26-000051.md) | [197](/filings/0000720005-26-000070.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 192,361,711 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0000720005-26-000070.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.